MedGenome
-
MedGenome partners with Darshan GIVA Foundation
To revolutionise TB diagnosis using whole genome sequencing MedGenome has partnered with Darshan GIVA Foundation, a non-governmental organisation, to pioneer…
Read More » -
Zydus launches IBYRA for cancer care
The drug will target specific genetic mutations prevalent in certain types of cancers Zydus has launched Olaparib, a PARP inhibitor,…
Read More » -
Decoding Genetic Metabolic Disorders
Dr Anup Rawool, Associate Director, Medical Genetics and Head, Scientific and Medical Affairs, MedGenome talks about the roadmap from detection…
Read More » -
Advancements in Therapeutic Approaches for Colorectal Cancer
By harnessing the body’s immune system to target and destroy cancer cells, immunotherapeutic approaches such as immune checkpoint inhibitors have…
Read More » -
MedGenome appoints Martin Dewhurst as Chairman of Advisory Board
Dewhurst is a healthcare investor, advisor, and board member with a focus on fostering growth and innovation, Dewhurst MedGenome announced…
Read More » -
Decoding Precision Therapy: Transformative Role of Omics Sciences
Personalised medicine will impact patients and healthcare systems in ways that could only have been imagined 15 years ago when…
Read More » -
MedGenome acquires Illumina’s NovaSeq X Plus, launches Genome Sequencing Test KaryoSeq
Becomes the first company to bring Illumina’s revolutionary Genome Sequencing Technology to South Asia MedGenome becomes the first to offer…
Read More » -
MedGenome acquires Prognosis Labs
The acquisition would help MedGenome strengthen its diagnostic foothold in North India Sequoia Capital-backed genomics-driven diagnostics and research startup MedGenome…
Read More » -
MedGenome Labs launches clonoSEQ Assay in India
clonoSEQ is the first US FDA-cleared MRD test for Multiple Myeloma, Chronic Lymphoblastic Leukaemia (CLL), and B-Acute Lymphoblastic Leukaemia (B-ALL)…
Read More »